Onego Bio and Sigma Foods Enter Collaboration to Strengthen Egg Protein Innovation and Supply Resilience
Onego Bio, a food ingredient company producing non-animal egg protein, and Sigma Foods ("SIGMA"), a leading multinational food company, have entered into a collaboration agreement to evaluate the functionality and commercial potential of Bioalbumen®, a non-animal egg protein made with using precision fermentation.
The partnership focuses on advancing ingredient innovation while addressing urgent challenges in today’s egg supply chain—including volatility, rising prices, and avian flu-related disruptions. Bioalbumen® offers a shelf-stable, animal-free alternative that delivers the same functional, nutritional, and sensory performance as traditional eggs, while helping safeguard supply continuity for food manufacturers.
Additionally, this collaboration supports Sigma’s commitment to offering safe, nutritious, and high-quality food, while driving science-based innovation through responsible ingredient sourcing. “At Sigma Foods, we are committed to delivering high-quality products in a sustainable and secure way,” said Gregorio De Haene, Chief Technology Officer at Sigma. “Our partnership with Onego Bio reflects our ambition to stay ahead of evolving consumer preferences by exploring innovative ingredients like non-animal egg protein. This collaboration allows us to further strengthen our sustainability journey while bringing new, future‑forward solutions to the table.”
Read the full press release here